Compare BEAM & SMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BEAM | SMG |
|---|---|---|
| Founded | 2017 | 1868 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.3B |
| IPO Year | 2019 | 2012 |
| Metric | BEAM | SMG |
|---|---|---|
| Price | $34.32 | $69.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | $50.75 | ★ $73.00 |
| AVG Volume (30 Days) | ★ 2.1M | 886.2K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.23% |
| EPS Growth | 82.31 | ★ 504.92 |
| EPS | N/A | ★ 1.93 |
| Revenue | $24,000.00 | ★ $3,016,500,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $33.77 | $2.63 |
| P/E Ratio | ★ N/A | $35.92 |
| Revenue Growth | ★ 33.33 | 6.17 |
| 52 Week Low | $15.60 | $52.00 |
| 52 Week High | $36.88 | $72.35 |
| Indicator | BEAM | SMG |
|---|---|---|
| Relative Strength Index (RSI) | 59.75 | 71.73 |
| Support Level | $26.96 | $58.34 |
| Resistance Level | $36.44 | $72.35 |
| Average True Range (ATR) | 2.18 | 2.46 |
| MACD | 0.34 | 1.08 |
| Stochastic Oscillator | 68.09 | 90.35 |
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.
Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The company sells a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat. Over half of revenue typically comes from Home Depot and Lowe's, as Scotts' products are featured at both home improvement retailers.